Literature DB >> 16536639

The fallacy of amyloid and cognition in Alzheimer's disease.

Hyoung-gon Lee, Xiongwei Zhu, George Perry, Mark A Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16536639     DOI: 10.2165/00002512-200623020-00007

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  12 in total

1.  Amyloid-beta junkies.

Authors:  G Perry; A Nunomura; A K Raina; M A Smith
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

2.  Predicting the failure of amyloid-beta vaccine.

Authors:  Mark A Smith; Craig S Atwood; James A Joseph; George Perry
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

Review 3.  Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.

Authors:  Hyoung-Gon Lee; Gemma Casadesus; Xiongwei Zhu; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

6.  Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.

Authors:  Ilse Dewachter; Delphine Reversé; Nathalie Caluwaerts; Laurence Ris; Cuno Kuipéri; Chris Van den Haute; Kurt Spittaels; Lieve Umans; Lutgarde Serneels; Els Thiry; Dieder Moechars; Mark Mercken; Emile Godaux; Fred Van Leuven
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 7.  The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease.

Authors:  Catherine A Rottkamp; Craig S Atwood; James A Joseph; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Peptides       Date:  2002-07       Impact factor: 3.750

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25

10.  Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity.

Authors:  B J Cummings; C W Cotman
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.